New Haven, CT · Founded 2013 · Privately Held (backing)
Developer of a precision therapeutics technology designed to treat cancer and rare diseases. OrphAI Therapeutics is based in New Haven, CT and was founded in 2013. Its last known valuation is $300 million. It has raised $155 million.
Last price · $/share
—
Implied valuation
$300.0M
Total raised
$154.5M
Last round
—
Team — not yet on record
No current team members for OrphAI Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of OrphAI Therapeutics with a free account
·Watch OrphAI Therapeutics: the Monday email on marks, rounds and moves
